Survivorship Care Linked to Better Cancer Outcomes

Head and neck cancer patients who attended early survivorship visits were more likely to finish radiation and had better three-year results.

Updated on Nov. 3, 2026 in Cancer

Gouache-painted editorial illustration of a smooth white radiotherapy mask resting flat on a pale surface, suggesting continuity of care after cancer treatment. — Head and neck cancer patients who attended early multidisciplinary survivorship visits were more likely to finish radiation, a retrospective study in JAMA Otolaryngology found. AI Illustration. Upload story photo >

Head and neck cancer patients who received early multidisciplinary survivorship care were more likely to complete their radiotherapy and had better three-year outcomes, according to a retrospective cohort study published October 22 in JAMA Otolaryngology-Head & Neck Surgery. The findings apply to patients who completed definitive curative-intent radiotherapy and attended such care.

Why it matters

Finishing the full course of radiation is central to curing head and neck cancer, and adherence has been a persistent challenge for many patients. The study suggests that structured support after treatment begins may help more patients stay on schedule and reduce the chance of recurrence.

This retrospective cohort study analyzed 471 patients with head and neck cancer who completed definitive curative-intent radiotherapy between 2018 and 2025. Survivorship care attendees showed lower nonadherence odds (0.45), lower three-year recurrence risk (0.62), and improved three-year disease-free survival (0.61) compared with non-attendees, using multivariable analysis adjusted for clinical and sociodemographic factors.

The players

JAMA Otolaryngology-Head & Neck Surgery

A peer-reviewed journal from the American Medical Association that publishes research on ear, nose, throat, and head and neck disorders, including cancers of these regions.

University of Pittsburgh School of Medicine

The medical school of the University of Pittsburgh, home to clinical and research programs in oncology and head and neck cancer care, where the lead researcher is affiliated.

The details

The researchers compared patients who attended early multidisciplinary survivorship visits with those who did not, tracking whether they stayed on their radiation schedule and how their cancer progressed. A multivariable model was used to account for differences in clinical characteristics and sociodemographic factors between the two groups. Because the comparison is observational, the results describe an association rather than proof that the visits themselves produced the gains.

Patients in the cohort were diagnosed and completed radiotherapy between March 21, 2018, and March 25, 2025.
The study was published online October 22 in JAMA Otolaryngology-Head & Neck Surgery.
HealthDay News reported on the study on November 3.

Health Landscape

Survivorship care, which focuses on the period after active cancer treatment, has become a growing area of clinical attention in oncology. This study adds to evidence that organized support during and after radiotherapy may matter as much as the treatment itself for head and neck cancer patients.

If you or a loved one is finishing radiation for a head or neck cancer, it is worth asking your care team whether a survivorship visit or similar follow-up program is available and how it fits your treatment plan. Staying on the prescribed radiation schedule matters, so bring up any barriers, such as transportation or side effects, with your doctor early.

The takeaway

Organized support after cancer treatment begins may help patients finish radiation and improve outcomes, though this study shows association rather than proof. Discuss with your physician whether survivorship care and treatment-adherence support are available to you.